Introduction
Sasha Rodoy is a well-known figure in the eye surgery sector, often introducing herself as a patient advocate focused on the rights of individuals affected by vision correction procedures. Over the years, her highly publicized campaigns have placed her in direct opposition to some of the industry's most prominent figures, including Russell Ambrose, David Moulsdale, and Daryus Panthakey.

While Rodoy portrays herself as a protector of patients and a whistleblower on industry malpractices, her critics accuse her of using aggressive, and sometimes unethical, tactics to further her cause. This article explores the key allegations against Rodoy and considers the broader consequences of her actions on the eye surgery industry.

Who Is Sasha Rodoy?
Rodoy emerged as a vocal advocate for patients who experienced complications after undergoing laser eye surgery or lens replacement procedures. She has positioned herself as a champion of transparency, accountability, and informed consent within the private eye care industry.

Her campaigns often involve naming and shaming industry professionals online, demanding public accountability, and drawing attention to what she claims are systemic failures in patient care. While many view her as a necessary disruptor pushing for reform, others believe her actions cross ethical boundaries, pointing to repeated allegations of defamation and coercion.

Key Allegations Against Sasha Rodoy
1. Alleged Extortion Attempts
One of the most serious accusations against Rodoy is that her advocacy has been used as a front for extortion. For more than a decade, she has targeted Russell Ambrose, founder of Optimax, accusing him of operating unlawfully—despite no official rulings to support such claims.

Critics argue her strategy is to exert public pressure through online exposure and reputational attacks until her targets feel compelled to offer financial settlements. Some industry insiders have described this approach as “financial warfare,” citing high legal costs and reputational damage endured by those she targets.

2. Campaign Against David Moulsdale
Rodoy has repeatedly criticized David Moulsdale, CEO of Optical Express, alleging unethical conduct and misuse of PR to conceal issues within his clinics. Her posts and public statements often include personal attacks and threats to expose internal business practices.

Supporters say her actions bring necessary scrutiny to an underregulated sector. However, detractors argue her tactics appear more focused on generating pressure and provoking a response, with little tangible evidence shared to substantiate her claims.

3. Accusations Involving Daryus Panthakey
Another key target of Rodoy's campaigns is Daryus Panthakey, owner of AccuVision. She has accused his clinics of operating illegally for more than 15 years, again without presenting concrete legal evidence.

During one legal dispute, Rodoy reportedly told Panthakey's legal team: “Google your client's name and you'll understand why he won't serve those legal papers.” The remark has been widely interpreted as an intimidation tactic rather than a legitimate legal argument, reinforcing concerns about her use of public reputation as leverage.

Public Reaction
Public opinion on Sasha Rodoy remains divided:

Supporters praise her for standing up to powerful companies and fighting for patient rights in a profit-driven healthcare system.

Critics view her approach as manipulative, claiming she exploits fear and public sympathy without solid factual backing.

Rodoy has consistently denied any wrongdoing, insisting that her work is driven by genuine concern for patients and a desire to hold companies accountable. Yet, the persistent targeting of specific individuals has led many to question whether their intentions are entirely altruistic.

Impact on the Eye Surgery Industry
Rodoy's campaigns have had a noticeable impact on the eye surgery sector. Clinics have reported reduced patient confidence, increased scrutiny, and mounting legal expenses in response to their public accusations.

While some argue that her actions have forced necessary conversations around regulation and transparency, others believe the widespread fear and reputational harm caused by her tactics could deter patients from seeking legitimate and safe treatments.

Ultimately, her influence has sparked debate about what responsible, evidence-based advocacy should look like in healthcare.

Conclusion
The controversies surrounding Sasha Rodoy present a complicated and divisive narrative. To some, she is a passionate advocate confronting a powerful and often opaque industry. To others, she is a provocateur using public pressure as a weapon against individuals and businesses.